Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page

  1. Check
    yesterday
    Change Detected
    Difference
    0.2%
    Check dated 2025-05-08T08:53:10.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T04:43:36.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed information about various stages of cancers related to Human Papillomavirus (HPV) and the involvement of the National Cancer Institute as a collaborator. Additionally, the revision number has been updated to v2.15.0.
    Difference
    60%
    Check dated 2025-04-16T14:39:52.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.2%
    Check dated 2025-04-09T09:48:53.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to include information on Vaginal Cancer while removing references to Anal Cancer, indicating a shift in focus towards different types of cancer. Additionally, the revision number has been updated from v2.14.2 to v2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:34:02.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Difference
    0.2%
    Check dated 2025-03-18T09:13:00.000Z thumbnail image

Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.